S

Standigm

45 employees

Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Drug Repurposing
Artificial Intelligence
Workflow AI
Pharmaceutical
AI Drug Discovery
Drug Discovery
Machine Learning
Deep Learning
Active Data Parsing
Bot Modeling
Health Care
NLP
Lead Generation
Target Identification
Biological Interpretation

Date founded

2015

Funding rounds raised

Total raised

$36M

from 10 investors over 10 rounds

S

Standigm raised $36M on March 5, 2021

Investors: Korea Development Bank Europe, LB Investment, Kakao Ventures, Daishin Securities and InterVest

S

Standigm raised $12M on March 1, 2019

Investors: DSC Investment, LB Investment and Kakao Ventures

S

Standigm raised $3M on August 1, 2016

Investors: LB Investment and Kakao Ventures

FAQ